GYN Oncology Clinical Nurse Specialist
UCLA Health
Los Angeles, CA
Amina Ahmed, MD, Paula Anastasia, RN, MN, AOCN, and Ali McBride, PharmD, describe their experiences in the use of niraparib, olaparib, and rucaparib as first-line maintenance therapy in ovarian cancer.